As of May 27
| +0.05 / +1.85%|
The 4 analysts offering 12-month price forecasts for OHR Pharmaceutical Inc have a median target of 22.50, with a high estimate of 34.00 and a low estimate of 3.00. The median estimate represents a +715.22% increase from the last price of 2.76.
The current consensus among 4 polled investment analysts is to Buy stock in OHR Pharmaceutical Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.